Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages 4060-4061

  Rapoport, Basil ^a   McLachlan, Sandra M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; THYROGLOBULIN; THYROID PEROXIDASE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; CAVEOLIN 1; IODIDE PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AFFINITY CHROMATOGRAPHY; ANTIBODY COMBINING SITE; CELLULAR IMMUNITY; DISEASE ASSOCIATION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MEDICAL LITERATURE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; METABOLISM; THYROID GLAND;

CAVEOLIN 1; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; NADPH OXIDASE; THYROID GLAND;

EID: 84910011163     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3011     Document Type: Note

References (10)

1. Marique L, Van Regemorter V, Gérard AC, et al. The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1/TH2) involved in thyroid autoimmune disorders. J Clin Endocrinol Metab. 2014;99: 1722-1732.
2. Siebenkotten G, Radbruch A. Towards a molecular understanding of immunoglobulin class switching. Immunologist. 1995;3: 141-145.
3. Aalberse RC, van der Gaag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol. 1983;130: 722-726.
4. Weetman AP, Yateman ME, Ealey PA, et al. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest. 1990;86: 723-727.
5. Evans M, Sanders J, Tagami T, et al. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol (Oxf). 2010;73: 404-412.
6. Latrofa F, Chazenbalk GD, Pichurin P, Chen CR, McLachlan SM, Rapoport B. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies. J Clin Endocrinol Metab. 2004;89: 4734-4745.
7. Nagayama Y. Graves' animal models of Graves' hyperthyroidism. Thyroid. 2007;17: 981-988.
8. McLachlan SM, Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid. 2004;14: 510-520.
9. McLachlan SM, Rapoport B. Thyroid peroxidase as an autoantigen. Thyroid. 2007;17: 939-948.
10. McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev. 2014;35: 59-105.